Rh
RH · NYSE
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.75 | -0.55 | -0.45 | 0.09 |
| FCF Yield | -2.76% | -1.33% | 3.13% | 5.56% |
| EV / EBITDA | 25.71 | 16.49 | 12.36 | 9.22 |
| Quality | ||||
| ROIC | 9.08% | 8.65% | 16.40% | 16.94% |
| Gross Margin | 44.48% | 45.86% | 50.47% | 49.36% |
| Cash Conversion Ratio | 0.24 | 1.59 | 0.76 | 0.96 |
| Growth | ||||
| Revenue 3-Year CAGR | -3.96% | -6.94% | 8.02% | 12.39% |
| Free Cash Flow Growth | -218.27% | -129.19% | -51.75% | 22.35% |
| Safety | ||||
| Net Debt / EBITDA | 8.62 | 6.86 | 2.89 | 1.18 |
| Interest Coverage | 1.57 | 1.53 | 4.92 | 13.95 |
| Efficiency | ||||
| Inventory Turnover | 1.70 | 2.10 | 2.16 | 2.52 |
| Cash Conversion Cycle | 177.41 | 142.18 | 144.56 | 106.09 |